看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| DURECT Corporation |
| Elite Pharmaceuticals, Inc. |
| Amneal Pharmaceuticals, Inc. |
| Indivior PLC |
| Collegium Pharmaceutical, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| DRRX | ELTP | AMRX | INDV | COLL | TEV | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -154% | -43% | 261% | 45% | 33% | -25% | ||
| Fiscal Year - 1 | -139% | 13% | -53% | 8% | 25% | -7% | ||
| Fiscal Year - 2 | -85% | 43% | -39% | -35% | -13% | -27% | ||
| Fiscal Year - 3 | -74% | 79% | 3% | 144% | 37% | 4% | ||
| Fiscal Year - 4 | -46% | 78% | 34% | -102% | 20% | -33% | ||
| Fiscal Year - 5 | -100% | -899% | -98% | 97% | -25% | -7% | ||
| Average | -100% | -122% | 18% | 26% | 13% | -16% | ||
| Median | -93% | 28% | -18% | 26% | 22% | -16% | ||
| Benchmarks | Ticker | |||||||
| DURECT Corporation | NasdaqCM:DRRX | |||||||
| Elite Pharmaceuticals, Inc. | PINC:ELTP | |||||||
| Amneal Pharmaceuticals, Inc. | NasdaqGS:AMRX | |||||||
| Indivior PLC | NasdaqGS:INDV | |||||||
| Collegium Pharmaceutical, Inc. | NasdaqGS:COLL | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | DRRX | ELTP | AMRX | INDV | COLL | TEV | ||
| Latest Fiscal Year | Dec-24 | Mar-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Mar-25 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 2 | 70 | 2,794 | 1,170 | 631 | 16,544 | ||
| Fiscal Year | 2 | 57 | 2,794 | 1,188 | 631 | 16,544 | ||
| Fiscal Year - 1 | 3 | 34 | 2,394 | 1,093 | 567 | 15,846 | ||
| Fiscal Year - 2 | 19 | 32 | 2,212 | 901 | 464 | 14,925 | ||
| Fiscal Year - 3 | 14 | 25 | 2,094 | 791 | 277 | 15,878 | ||
| Fiscal Year - 4 | 30 | 18 | 1,993 | 647 | 310 | 16,659 | ||
| Fiscal Year - 5 | 25 | 8 | 1,626 | 785 | 297 | 16,887 | ||
| Net Income | ||||||||
| Latest Twelve Months | (18) | (18) | (117) | (62) | 69 | (1,639) | ||
| Fiscal Year | (18) | 20 | (117) | (48) | 69 | (1,639) | ||
| Fiscal Year - 1 | (28) | 4 | (84) | 2 | 48 | (559) | ||
| Fiscal Year - 2 | (35) | 9 | (130) | (44) | (25) | (2,446) | ||
| Fiscal Year - 3 | (36) | 5 | 11 | 205 | 72 | 417 | ||
| Fiscal Year - 4 | (14) | (2) | 91 | (148) | 27 | (3,990) | ||
| Fiscal Year - 5 | (21) | (9) | (362) | 134 | (23) | (999) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 45 | 75 | 3,473 | 1,453 | 1,143 | 43,479 | ||
| Latest Fiscal Quarter | 18 | 91 | 3,501 | 1,375 | 1,664 | 39,326 | ||
| Fiscal Year | 18 | 84 | 3,501 | 1,466 | 1,664 | 39,326 | ||
| Fiscal Year - 1 | 45 | 41 | 3,473 | 1,948 | 1,143 | 43,479 | ||
| Fiscal Year - 2 | 60 | 35 | 3,799 | 1,769 | 1,174 | 44,011 | ||
| Fiscal Year - 3 | 92 | 26 | 3,940 | 1,832 | 692 | 47,666 | ||
| Fiscal Year - 4 | 76 | 25 | 4,006 | 1,531 | 644 | 50,640 | ||
| Fiscal Year - 5 | 86 | 24 | 3,666 | 1,652 | 306 | 57,470 | ||
| Fiscal Year - 6 | 50 | 31 | 4,353 | 1,547 | 291 | 60,683 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 15 | 46 | 20 | 10 | 195 | 7,506 | ||
| Latest Fiscal Quarter | 9 | 36 | (109) | (285) | 229 | 5,373 | ||
| Fiscal Year | 9 | 58 | (109) | (205) | 229 | 5,373 | ||
| Fiscal Year - 1 | 15 | 29 | 20 | 0 | 195 | 7,506 | ||
| Fiscal Year - 2 | 25 | 25 | 298 | 51 | 195 | 7,804 | ||
| Fiscal Year - 3 | 58 | 16 | 360 | 203 | 203 | 10,278 | ||
| Fiscal Year - 4 | 40 | (3) | 303 | 82 | 186 | 10,026 | ||
| Fiscal Year - 5 | 23 | (3) | 232 | 209 | 87 | 13,972 | ||
| Fiscal Year - 6 | 20 | 5 | 505 | 66 | 92 | 14,707 | ||